Insider trades
Ryan Cohlhepp, COO of Bicara Therapeutics BCAX, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $2.8M. The latest trade was on 05/15.
Ryan Cohlhepp
President and COO
- Company
- Bicara Therapeutics BCAX
- First filing
- 25/12/16
- Trades
- 45 trades
- Buys / sales
- 0 / 22
- 12-month net buying
- −$2.8M
- Last trade
- 05/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
BCAX | Open-market sale10b5-1 plan | 05/15 | 05/18 | 12,500 sh2 trades | $20.29avg. | $253,625 | −6.1% |
BCAX | Open-market sale10b5-1 plan | 04/15 | 04/17 | 12,500 sh2 trades | $23.01avg. | $287,625 | −6.0% |
BCAX | Open-market sale10b5-1 plan | 03/16 | 03/17 | 12,500 sh2 trades | $19.66avg. | $245,750 | −5.9% |
BCAX | Open-market sale10b5-1 plan | 03/03 | 03/05 | 17,392 sh2 trades | $18.16avg. | $315,838.72 | −7.8% |
BCAX | Open-market sale10b5-1 plan | 02/25 | 02/27 | 3,631 sh2 trades | $18.04avg. | $65,503.24 | −1.7% |
| Open-market sale10b5-1 plan | 01/22 | 01/26 | 3,828 sh | $18.10 | $69,286.8 | −1.8% | |
| Open-market sale10b5-1 plan | 01/15 | 01/20 | 149 sh | $18.02 | $2,684.98 | −0.1% | |
BCAX | Open-market sale10b5-1 plan | 25/12/15 | 25/12/16 | 12,500 sh2 trades | $18.68avg. | $233,500 | −6.2% |
BCAX | Open-market sale10b5-1 plan | 25/11/21 | 25/11/25 | 12,500 sh2 trades | $18.05avg. | $225,625 | −6.1% |
BCAX | Open-market sale10b5-1 plan | 25/10/15 | 25/10/16 | 12,500 sh2 trades | $18.16avg. | $227,000 | −5.9% |
BCAX | Open-market sale10b5-1 plan | 25/10/06–25/10/07 | 25/10/08 | 50,500 sh4 trades | $18.06avg. | $912,030 | −19.9% |